Medifast (NYSE:MED) Gets an Upgrade to a “Neutral” Rating

November 9, 2018 - By Ruchi Gupta

Medifast, Inc. (NYSE:MED) Logo

Investors sentiment increased to 1.48 in 2018 Q2. Its up 0.20, from 1.28 in 2018Q1. It increased, as 18 investors sold Medifast, Inc. shares while 66 reduced holdings. 52 funds opened positions while 72 raised stakes. 10.04 million shares or 0.04% more from 10.03 million shares in 2018Q1 were reported.

Jpmorgan Chase And accumulated 45,277 shares or 0% of the stock. Usa Financial Portformulas reported 1,400 shares. X Mngmt Ltd Llc holds 0% of its portfolio in Medifast, Inc. (NYSE:MED) for 190 shares. Art Advisors Limited Liability Co stated it has 0.05% of its portfolio in Medifast, Inc. (NYSE:MED). Sei reported 16,516 shares. Systematic Mgmt L P has invested 0.04% of its portfolio in Medifast, Inc. (NYSE:MED). Arrowstreet Cap Limited Partnership holds 0.09% of its portfolio in Medifast, Inc. (NYSE:MED) for 230,622 shares. Lpl Fin holds 0% of its portfolio in Medifast, Inc. (NYSE:MED) for 3,897 shares. Osterweis Cap Mngmt has invested 0.44% in Medifast, Inc. (NYSE:MED). Comerica National Bank & Trust invested 0.01% in Medifast, Inc. (NYSE:MED). Blackrock Inc invested in 0.01% or 1.54M shares. Prelude Capital Mngmt Limited Liability stated it has 1,305 shares. Amundi Pioneer Asset Management Incorporated stated it has 35,132 shares or 0.01% of all its holdings. Bank Of Montreal Can reported 0% in Medifast, Inc. (NYSE:MED). Us Bank De accumulated 699 shares.

Medifast (NYSE:MED) Stock Upgrade

Medifast (NYSE:MED) was raised by Sidoti \u0026 Co. from a “Neutral” rating to a solid “Buy” rating in an analyst report issued to clients and investors on Thursday morning.

The stock increased 0.82% or $1.25 during the last trading session, reaching $154.56. About 656,186 shares traded or 129.60% up from the average. Medifast, Inc. (NYSE:MED) has risen 363.41% since November 9, 2017 and is uptrending. It has outperformed by 347.79% the S&P500.

Medifast, Inc., through its subsidiaries, makes and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products. The company has market cap of $1.85 billion. It offers bars, bites, pretzels, puffs, oatmeal and cereal crunch products, drinks, hearty choices, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by OPTAVIA, Flavors of Home, and Essential 1 brands. It has a 46.55 P/E ratio. The firm sells its products through various channels, including the Internet, call centers, independent health advisors, medical professionals, franchise weight loss clinics, and direct consumer marketing.

More recent Medifast, Inc. (NYSE:MED) news were published by: Seekingalpha.com which released: “Medifast, Inc. (MED) CEO Dan Chard on Q3 2018 Results – Earnings Call Transcript” on November 07, 2018. Also Benzinga.com published the news titled: “70 Stocks Moving In Wednesday’s Mid-Day Session” on November 07, 2018. Benzinga.com‘s news article titled: “88 Biggest Movers From Yesterday” with publication date: November 08, 2018 was also an interesting one.

Medifast, Inc. (NYSE:MED) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>